Filing Details
- Accession Number:
- 0001209191-19-015649
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-03-04 16:34:13
- Reporting Period:
- 2019-02-28
- Accepted Time:
- 2019-03-04 16:34:13
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1293971 | Bluebird Bio Inc. | BLUE | Biological Products, (No Disgnostic Substances) (2836) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1725663 | James Kory Wentworth | C/O Bluebird Bio, Inc. 60 Binney Street Cambridge MA 02142 | Principal Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-02-28 | 51 | $151.71 | 6,695 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The shares reported as sold herein were originally acquired under the bluebird bio, Inc. employee stock purchase plan on January 31, 2019.
Billionaire Hedge Funds
